Inflammation and surfactant

Paediatric Respiratory Reviews

Volumn 3, Issue 4, 2002, Pages 308-314

  Meyer, Keith C ^a   Zimmerman, Jerry J ^b  

^a University of Wisconsin Health   (United States)

^b SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

Author keywords

Asthma; Cystic fibrosis; Interstitial lung disease; Lung disease; Lung transplantation; Pulmonary surfactant; Respiratory distress syndrome

Indexed keywords

ARTIFICIAL LUNG SURFACTANT; COLLECTIN; KL 4; LUCINACTANT; LUNG SURFACTANT; LUNG SURFACTANT EXTRACT; LUSUPULTIDE; PHOSPHOLIPID; RECOMBINANT PROTEIN; SURFACTANT ASSOCIATED PROTEIN; SURFACTANT PROTEIN A; SURFACTANT PROTEIN B; SURFACTANT PROTEIN C; SURFACTANT PROTEIN D; UNCLASSIFIED DRUG;

ASTHMA; BREATHING; CYSTIC FIBROSIS; HOST RESISTANCE; HUMAN; INTERSTITIAL LUNG DISEASE; LUNG DYSPLASIA; LUNG INFECTION; LUNG PARENCHYMA; PRIORITY JOURNAL; RESPIRATORY DISTRESS SYNDROME; RESPIRATORY TRACT INFLAMMATION; REVIEW; SURFACE TENSION; AGE; CHILD; INFANT; INFLAMMATION; NEWBORN; RESPIRATORY TRACT DISEASE;

AGE FACTORS; CHILD; HUMANS; INFANT; INFANT, NEWBORN; INFLAMMATION; PULMONARY SURFACTANTS; RESPIRATORY TRACT DISEASES;

EID: 0036887224     PISSN: 15260550     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1043-6618(02)00212-8     Document Type: Review

References (40)

1. LeVine AM, Whitsett JA. Pulmonary collectins and innate host defense of the lung. Microbes infect 2001; 3: 161-166.
2. LeVine AM, Kurak KE, Bruno MD et al. Surfactant protein-A-deficient mice are susceptible to Pseudomonas aeruginosa infection. Am J Respir Cell Mol Biol 1998; 19: 700-708.
3. Li G, Siddiqui J, Hendry M et al. Surfactant protein-A-deficient mice display an exaggerated early inflammatory response to a β-resistant strain of influenza A virus. Am J Respir Cell Mol Biol 2002; 26: 277-282.
4. Crouch E, Wright JR. Surfactant proteins A and D and pulmonary host defense. Annu Rev Physiol 2001; 63: 521-554.
5. Notter RH. Lung surfactants. In Lenfant C (ed.). Lung Biology in Health and Disease. New York: Marcel Dekker, Inc, 2000; pp. 233-248.
6. Morley CJ, Brown BD, Hill CM, Barson AJ, Davis JA. Surfactant abnormalities in babies dying from sudden infant death syndrome. Lancet 1982; 1: 1320-1322.
7. Taieb J, Francoual J, Magny JF, Fraslon C, Massaoudi C. Surfactant associated protein A determination using a chemiluminescence system - application to tracheal aspirates from newborn. Clin Chim Acta 1995; 235: 229-234.
8. Bhatt AJ, Pryhuber GS, Huyck H et al. Disrupted pulmonary vasculature and decreased vascular endothelial growth factor, Flt-1, and TIE-2 in human infants dying with bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001; 164: 1971-1980.
9. Findlay RD, Taeusch HW, Walther FJ. Surfactant replacement therapy for meconium aspiration syndrome. Pediatrics 1996; 97: 48-52.
10. Lotze A, Mitchell B, Bulas D et al. Multicenter study of surfactant (berectant) use in the treatment of term infants with severe respiratory failure. Survanta in Term Infants Study Group. J Pediatr 1998; 132: 40-47.
11. Anzueto A, Baughman RP, Guntupalli KK et al. Aerosolized surfactant in adults with sepsis-induced acute respiratory distress syndrome. New Engl J Med 1996; 334: 1417-1421.
12. Gregory T, Steinberg KP, Spragg R et al. Bovine surfactant therapy for patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 1997; 155: 1309-1315.
13. Spragg RG, Gilliard N, Richman P et al. Acute effects of a single dose of porcine surfactant on patients with the adult respiratory distress syndrome. Chest 1994; 105: 195-202.
14. Walmrath D, De Vaal JB, Bruining HA et al. Treatment of ARDS with rSP-C surfactant. Am J Respir Crit Care Med 2000; 161: A379 (Abstract).
15. Wiswell TE, Smith RM, Katz LB et al. Bronchopulmonary segmental lavage with Surfaxin (KL4-Surfactant) for acute respiratory distress syndrome. Am J Respir Crit Care Med 1999; 160: 1188-1195.
16. Wilson DF, Jiao JH, Bauman LA et al. Calf s lung surfactant extract in acute hypoxemic respiratory failure in children. Crit Care Med 1996; 24: 1316-1322.
17. Enhoming G, Duffy LC, Welliver RC. Pulmonary surfactant maintains patency of conducting airways in the rat. Am J Respir Crit Care Med 1995; 151: 554-556.
18. Liu M, Wang L, Li E, Enhoming G. Pulmonary surfactant given prophylactically alleviates an asthma attack in guinea-pigs. Clin Exp Allergy 1996; 26: 270-275.
19. Kurashima K, Ogawa H, Ohka T et al. A pilot study of surfactant inhalation for the treatment of asthma attack. Arerugi-Jap J Allergy 1991; 40: 160-163.
20. Hohlfeld JM, Ahif K, Enhoming G et al. Dysfunction of pulmonary surfactant in asthmatics after segmental allergen challenge. Am J Respir Crit Care Med 1999; 159: 1803-1809.
21. Jarjour NN, Enhörning G. Antigen-induced airway inflammation in atopic subjects generates dysfunction of pulmonary surfactant. Am J Respir Crit Care Med 1999; 160: 336-341.
22. Heeley EL, Hohlfeld JM, Krug N, Postle AD. Phospholipid molecular species of bronchoalveolar lavage fluid after local allergen challenge in asthma. Am J Physiol Lung Cell Mol Physiol 2000; 278: L305-L311.
23. Wang JY, Kishore U, Lim BL. Strong P, Reid KBM. Interaction of human lung surfactant protein A and D with mite (Dermatophagoides pteronyssinus) allergens. Clin Exp Immunol 1996; 106: 367-373.
24. Wang JY, Shieh CC, You PF, Lei HY, Reid KBM. Inhibitory effect of pulmonary surfactant proteins A and D on allergen-induced lymphocyte proliferation and histamine release in children with asthma. Am J Respir Crit Care Med 1998; 158: 510-518.
25. Malhotra R, Haurum J, Thiel S, Jensenius JC, Sim RB. Pollen grains bind to alveolar type II cells (A549) via lung surfactant protein A (SPA). Biosci Rep 1993; 13: 79-90.
26. Van de Graaf EA, Jansen HM, Lutter R et al. Surfactant protein A in bronchoalveolar lavage fluid. J Lab Clin Med 1992; 120: 252-263.
27. Griese M, Birrer P, Demirsoy A. Pulmonary surfactant in cystic fibrosis. Eur RespirJ 1997; 10: 1983-1988.
28. Meyer KC, Sharma A, Brown R et al. Function and composition of pulmonary surfactant and surfactant-derived fatty acid profiles are altered in young adults with cystic fibrosis, Chest 2000; 118: 164-174.
29. Von Bredow C, Birrer P, Griese M. Surfactant protein A and other bronchoalveolar lavage fluid proteins are altered in cystic fibrosis. Eur Respir J 2001; 17: 716-722.
30. Günther A, Siebert C, Schmidt R et al. Surfactant alterations in severe pneumonia, acute respiratory distress syndrome, and cardiogenic lung edema. Am J Respir Crit Care Med 1996; 153: 176-184.
31. McCormack FX, King TE, Bucher BL, Nielsen L. Surfactant protein A predicts survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1995; 152: 751-759.
32. Thomas AQ, Lane K, Phillips J III et al. Heterozygosity for a surfactant protein C gene mutation associated with usual interstitial pneumonitis and cellular nonspecific interstitial pneumonitis in one kindred. Am J Respir Crit Care Med 2002; 165: 1322-1328.
33. Andrade RS, Solien EE, Wangansteen OD et al. Surfactant dysfunction in lung preservation. Transplantation 1995; 60: 536-541.
34. Novick RJ, Gilpin AA, Gehman KE et al. Mitigation of injury in canine lung grafts by exogenous surfactant therapy. J Thorac Cardiovasc Surg 1997; 113: 342-353.
35. Maitra G, Inchley K, Novick RJ et al. Acute lung injury and lung transplantation influence in vitro subtype conversion of pulmonary surfactant. Am J Physiol Lung Cell Mol Physiol 2002; 282: L67-74.
36. Erasmus ME, Hofstede GJ, Petersen AH et al. SP-A-enriched surfactant for treatment of rat lung transplants with SP-A deficiency after storage and reperfusion. Transplantation 2002; 73: 348-352.
37. Hohlfeld JM, Struber J, Ahlf K et al. Exogenous surfactant improves survival and surfactant function in ischaemia-reperfusion injury in minipigs. Eur Respir J 1999; 13: 1037-1043.
38. Hausen B, Rohde R, Hewitt CW et al. Exogenous surfactant treatment before and after sixteen hours of ischemia in experimental lung transplantation. J Thorac Cardiovasc Surg 1997; 113: 1050-1058.
39. Hohlfeld JM, Tiryaki E, Hamm H et al. Pulmonary surfactant activity is impaired in lung transplant recipients. Am J Respir Crit Care Med 1998; 158: 706-712.
40. Struber M, Hirt SW, Cremer J, Harringer W, Haverich A. Surfactant replacement in reperfusion injury after clinical lung transplantation. Intensive Care Med 1999; 25: 862-864.